Found: 57
Select item for more details and to access through your institution.
Comparison of the freiburg and charlson comorbidity indices in predicting overall survival in elderly patients with newly diagnosed multiple myeloma.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Comparison of the Freiburg and Charlson Comorbidity Indices in Predicting Overall Survival in Elderly Patients with Newly Diagnosed Multiple Myeloma.
- Published in:
- BioMed Research International, 2014, v. 2014, p. 1, doi. 10.1155/2014/437852
- By:
- Publication type:
- Article
Clinical Utility of a Diagnostic Approach to Detect Genetic Abnormalities in Multiple Myeloma: A Single Institution Experience.
- Published in:
- Annals of Laboratory Medicine, 2018, v. 38, n. 3, p. 196, doi. 10.3343/alm.2018.38.3.196
- By:
- Publication type:
- Article
Clinical Practice Recommendations for the Use of Next-Generation Sequencing in Patients with Solid Cancer: A Joint Report from KSMO and KSP.
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 3, p. 721, doi. 10.4143/crt.2023.1043
- By:
- Publication type:
- Article
Neoadjuvant Nivolumab Therapy for Esophageal Squamous Cell Carcinoma: A Single-Arm, Phase II Study.
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 2, p. 567, doi. 10.4143/crt.2023.897
- By:
- Publication type:
- Article
First-Line Alectinib vs. Brigatinib in Advanced Non-Small Cell Lung Cancer with ALK Rearrangement: Real-World Data.
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 1, p. 61, doi. 10.4143/crt.2023.461
- By:
- Publication type:
- Article
Expanded Access Program Pralsetinib in Advanced Non-Small Cell Lung Cancer with Rearranged during Transfection (RET) Gene Rearrangement.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 4, p. 1144, doi. 10.4143/crt.2023.403
- By:
- Publication type:
- Article
Phase II Trial of Combined Durvalumab Plus Tremelimumab with Proton Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 4, p. 1104, doi. 10.4143/crt.2023.502
- By:
- Publication type:
- Article
EGFR Mutation-Positive Unresectable Stage III Non-Squamous Lung Cancer Is Associated with a High Incidence of Brain Metastasis.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 2, p. 498, doi. 10.4143/crt.2022.388
- By:
- Publication type:
- Article
The Role of Brain Radiotherapy before First-Line Afatinib Therapy, Compared to Gefitinib or Erlotinib, in Patients with EGFR-Mutant Non-Small Cell Lung Cancer.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 2, p. 479, doi. 10.4143/crt.2022.1344
- By:
- Publication type:
- Article
Osimertinib Combined with Systemic Chemotherapy for EGFR Mutant, T790M-Negative, Non–Small Cell Lung Cancer Patients Who Develop Leptomeningeal Metastases with Extracranial Progression to Prior EGFR TKI.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 1, p. 344, doi. 10.4143/crt.2021.1603
- By:
- Publication type:
- Article
A Single-Arm, Prospective, Phase II Study of Cisplatin Plus Weekly Docetaxel as First-Line Therapy in Patients with Metastatic or Recurrent Salivary Gland Cancer.
- Published in:
- Cancer Research & Treatment, 2022, v. 54, n. 3, p. 719, doi. 10.4143/crt.2021.1019
- By:
- Publication type:
- Article
Long-term Survival in Non-Small Cell Lung Cancer Patients with Metachronous Brain-Only Oligorecurrence Who Underwent Definitive Treatment.
- Published in:
- Cancer Research & Treatment, 2022, v. 54, n. 1, p. 150, doi. 10.4143/crt.2021.306
- By:
- Publication type:
- Article
EGFR C797S as a Resistance Mechanism of Lazertinib in Non-small Cell Lung Cancer with EGFR T790M Mutation.
- Published in:
- Cancer Research & Treatment, 2020, v. 52, n. 4, p. 1288, doi. 10.4143/crt.2020.278
- By:
- Publication type:
- Article
Clinical Characteristics and Outcomes of Non-small Cell Lung Cancer Patients with HER2 Alterations in Korea.
- Published in:
- Cancer Research & Treatment, 2020, v. 52, n. 1, p. 292, doi. 10.4143/crt.2019.186
- By:
- Publication type:
- Article
Feasibility Study of Physician Orders for Life-Sustaining Treatment for Patients with Terminal Cancer.
- Published in:
- Cancer Research & Treatment, 2019, v. 51, n. 4, p. 1632, doi. 10.4143/crt.2019.009
- By:
- Publication type:
- Article
Impact on Survival of Regular Postoperative Surveillance for Patients with Early Breast Cancer.
- Published in:
- Cancer Research & Treatment, 2015, v. 47, n. 4, p. 765, doi. 10.4143/crt.2014.168
- By:
- Publication type:
- Article
Changes in the Mean Corpuscular Volume after Capecitabine Treatment Are Associated with Clinical Response and Survival in Patients with Advanced Gastric Cancer.
- Published in:
- Cancer Research & Treatment, 2015, v. 47, n. 1, p. 72, doi. 10.4143/crt.2013.172
- By:
- Publication type:
- Article
Nomogram to Predict Treatment Outcome of Fluoropyrimidine/ Platinum-Based Chemotherapy in Metastatic Esophageal Squamous Cell Carcinoma.
- Published in:
- Cancer Research & Treatment, 2013, v. 45, n. 4, p. 285, doi. 10.4143/crt.2013.45.4.285
- By:
- Publication type:
- Article
Epidemiology and Outcomes of Non–Small Cell Lung Cancer in South Korea.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 2, p. e2355331, doi. 10.1001/jamanetworkopen.2023.55331
- By:
- Publication type:
- Article
Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer with Brain Metastasis : The Role of Gamma Knife Radiosurgery.
- Published in:
- Journal of Korean Neurosurgical Society, 2021, v. 64, n. 2, p. 271, doi. 10.3340/jkns.2020.0135
- By:
- Publication type:
- Article
Bevacizumab plus irinotecan with or without gamma knife radiosurgery after failure of concurrent chemo-radiotherapy for high-grade glioma.
- Published in:
- Journal of Neuro-Oncology, 2022, v. 156, n. 3, p. 541, doi. 10.1007/s11060-021-03930-4
- By:
- Publication type:
- Article
Treatment and Outcomes of Metastatic Pancreatic Cancer in Elderly Patients.
- Published in:
- Chemotherapy (0009-3157), 2021, v. 66, n. 4, p. 107, doi. 10.1159/000517245
- By:
- Publication type:
- Article
Treatment Outcome and Relevance of Palliative Chemotherapy in Urachal Cancer.
- Published in:
- Chemotherapy (0009-3157), 2015, v. 60, n. 2, p. 73, doi. 10.1159/000368071
- By:
- Publication type:
- Article
Multimodal treatments and outcomes for anaplastic thyroid cancer before and after tyrosine kinase inhibitor therapy: a real-world experience.
- Published in:
- European Journal of Endocrinology, 2021, v. 184, n. 6, p. 837, doi. 10.1530/EJE-20-1482
- By:
- Publication type:
- Article
Pulmonary function and toxicities of proton versus photon for limited-stage small cell lung cancer.
- Published in:
- Radiation Oncology Journal, 2023, v. 41, n. 4, p. 274, doi. 10.3857/roj.2023.00773
- By:
- Publication type:
- Article
Prognostic value of FOXP3+ regulatory T cells for patients with locally advanced oropharyngeal squamous cell carcinoma.
- Published in:
- PLoS ONE, 2022, v. 17, n. 10, p. 1, doi. 10.1371/journal.pone.0274830
- By:
- Publication type:
- Article
Clinical outcomes of immune checkpoint inhibitors for patients with recurrent or metastatic head and neck cancer: real-world data in Korea.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Impact of EGFR mutation on the clinical efficacy of PD-1 inhibitors in patients with pulmonary adenocarcinoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 5, p. 1341, doi. 10.1007/s00432-019-02889-0
- By:
- Publication type:
- Article
Tyrosine Kinase Inhibitor Activity in Patients with NSCLC Harboring Uncommon EGFR Mutations: A Retrospective International Cohort Study (UpSwinG).
- Published in:
- Oncologist, 2022, v. 27, n. 4, p. 255, doi. 10.1093/oncolo/oyac022
- By:
- Publication type:
- Article
Benefit of Targeted DNA Sequencing in Advanced Non-Small-Cell Lung Cancer Patients Without EGFR and ALK Alterations on Conventional Tests.
- Published in:
- 2020
- By:
- Publication type:
- journal article
PD‐1 inhibitors for non‐small cell lung cancer patients with special issues: Real‐world evidence.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 7, p. 2352, doi. 10.1002/cam4.2868
- By:
- Publication type:
- Article
Comparative effectiveness of palliative chemotherapy versus neoadjuvant chemotherapy followed by radical cystectomy versus cystectomy followed by adjuvant chemotherapy versus cystectomy for regional node‐positive bladder cancer: A retrospective analysis: KCSG GU 17‐03
- Published in:
- Cancer Medicine, 2019, v. 8, n. 12, p. 5431, doi. 10.1002/cam4.2446
- By:
- Publication type:
- Article
Immune checkpoint inhibitor use and the incidence of hepatitis B virus reactivation or immune‐related hepatitis in non–small cell lung cancer patients with chronic hepatitis B.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 9, p. 1693, doi. 10.1002/cncr.35175
- By:
- Publication type:
- Article
Biomarker‐driven phase 2 umbrella trial: Clinical efficacy of olaparib monotherapy and combination with ceralasertib (AZD6738) in small cell lung cancer.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 4, p. 541, doi. 10.1002/cncr.35059
- By:
- Publication type:
- Article
A phase 2 multicenter study of docetaxel‐PM and trastuzumab‐pkrb combination therapy in recurrent or metastatic salivary gland carcinomas.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 19, p. 2966, doi. 10.1002/cncr.34892
- By:
- Publication type:
- Article
High concordance of actionable genomic alterations identified between circulating tumor DNA–based and tissue‐based next‐generation sequencing testing in advanced non–small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy Program
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 16, p. 3019, doi. 10.1002/cncr.33571
- By:
- Publication type:
- Article
Biomarker-driven phase 2 umbrella trial study for patients with recurrent small cell lung cancer failing platinum-based chemotherapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
High-throughput profiling identifies clinically actionable mutations in salivary duct carcinoma.
- Published in:
- Journal of Translational Medicine, 2014, v. 12, n. 1, p. 1, doi. 10.1186/s12967-014-0299-6
- By:
- Publication type:
- Article
High-throughput profiling identifies clinically actionable mutations in salivary duct carcinoma.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Treatment and Outcomes of Metastatic Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: Are They Different from Those with Common EGFR Mutations?
- Published in:
- Biology (2079-7737), 2020, v. 9, n. 10, p. 326, doi. 10.3390/biology9100326
- By:
- Publication type:
- Article
Markedly increased ocular side effect causing severe vision deterioration after chemotherapy using new or investigational epidermal or fibroblast growth factor receptor inhibitors.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A multicenter, phase II trial of GC1118, a novel anti‐EGFR antibody, for recurrent glioblastoma patients with EGFR amplification.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 15, p. 15788, doi. 10.1002/cam4.6213
- By:
- Publication type:
- Article
Longitudinal monitoring by next‐generation sequencing of plasma cell‐free DNA in ALK rearranged NSCLC patients treated with ALK tyrosine kinase inhibitors.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 15, p. 2944, doi. 10.1002/cam4.4663
- By:
- Publication type:
- Article
Presence of anaplastic lymphoma kinase translocation in sarcomatoid carcinoma of head and neck and treatment effect of crizotinib: A case series.
- Published in:
- Head & Neck, 2015, v. 37, n. 5, p. E66, doi. 10.1002/hed.23884
- By:
- Publication type:
- Article
Nivolumab for esophageal squamous cell carcinoma and the predictive role of PD-L1 or CD8 expression in its therapeutic effect.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1203, doi. 10.1007/s00262-020-02766-7
- By:
- Publication type:
- Article
Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-16164-1
- By:
- Publication type:
- Article
Lazertinib versus Platinum-Based Chemotherapy with Epidermal Growth Factor Receptor (EGFR)-Positive Non-Small-Cell Lung Cancer after Failing EGFR-Tyrosine Kinase Inhibitor: A Real-World External Comparator Study.
- Published in:
- Cancers, 2024, v. 16, n. 12, p. 2169, doi. 10.3390/cancers16122169
- By:
- Publication type:
- Article
Real-World Outcomes of Immunotherapy in Second- or Later-Line Non-Small Cell Lung Cancer with Actionable Genetic Alterations.
- Published in:
- Cancers, 2023, v. 15, n. 22, p. 5450, doi. 10.3390/cancers15225450
- By:
- Publication type:
- Article
Prognostic Value of the Neutrophil-to-Lymphocyte Ratio before and after Radiotherapy for Anaplastic Thyroid Carcinoma.
- Published in:
- Cancers, 2021, v. 13, n. 8, p. 1913, doi. 10.3390/cancers13081913
- By:
- Publication type:
- Article